FeesSafety
Pluang+

Artivion to present at two major healthcare investor conferences in November 2026

Market News
28 Oct 2026, 23:10 WIB
PRNewsWire
View Source
Neutral
Artivion to present at two major healthcare investor conferences in November 2026

Artivion, a leading company in cardiac and vascular surgery focused on aortic disease, announced it will present at the Stifel 2026 Healthcare Conference on November 10 and the 20th Annual Canaccord Genuity MedTech Forum on November 11. These presentations will be webcast live and archived for 90 days on Artivion's website. This participation highlights Artivion's ongoing engagement with investors and its focus on advancing solutions for aortic disease treatment. Investors can access detailed updates and insights directly from the company's management during these events.

Artivion's upcoming participation in investor conferences provides context for market watchers. For readers following the health sector, here is Pluang's market snapshot as of Oct 29, 2026 02:12 WIB: Out of 150 priced health-sector US stocks, 87 rose and 62 fell. Notable movers include INO (Inovio Pharmaceuticals Inc) at USD 0.94 with a 1-day change of +6.09%, RXRX (Recursion Pharmaceuticals Inc) at USD 4.27 with +5.43%, and BFLY (Butterfly Network Inc. Class A Common Stock) at USD 7.76 with +5.15%.

More News

SpaceX Q3 revenue soars 161% to $14.6B with Starlink adding 1.6M users and strong profit growth.

SpaceX Q3 revenue soars 161% to $14.6B with Starlink adding 1.6M users and strong profit growth.

SpaceX reported a strong Q3 with revenue up 161% year-over-year to $14.6 billion and a net profit of $4.4 billion, reversing last year's loss. Starlink, its satellite internet service, grew revenue by nearly 70% to $5.2 billion and added 1.6 million ...

Company Fundamentals
Bullish
35 minutes ago
SPIE to acquire 76% of SAR ANLAGENBAU GmbH, expanding its electrical services in Austria and Germany.

SPIE to acquire 76% of SAR ANLAGENBAU GmbH, expanding its electrical services in Austria and Germany.

SPIE, a leading European multi-technical services provider, has signed an agreement to acquire a 76% stake in SAR ANLAGENBAU GmbH, a major electrical engineering and automation firm based in Austria and Germany. This acquisition will enhance SPIE's p...

Company Fundamentals
Bullish
2 hours ago
SPIE to acquire 76% stake in SAR ANLAGENBAU, expanding electrical services in Austria and Germany

SPIE to acquire 76% stake in SAR ANLAGENBAU, expanding electrical services in Austria and Germany

SPIE, a European leader in energy and communication services, has agreed to acquire a 76% stake in SAR ANLAGENBAU GmbH, a key electrical engineering and automation firm in Austria and Germany. This acquisition will broaden SPIE's service portfolio in...

Company Fundamentals
Bullish
2 hours ago
Global dermatological therapeutics market to reach $97B by 2034, driven by rising skin disorders and advanced treatments.

Global dermatological therapeutics market to reach $97B by 2034, driven by rising skin disorders and advanced treatments.

The global dermatological therapeutics market is projected to grow from about $43 billion in 2025 to $97 billion by 2034, with a compound annual growth rate of around 10%. This growth is fueled by increasing cases of acne, psoriasis, and other chroni...

Bullish
3 hours ago
TRX options launch on Blockchain.com, boosting global access to TRON's blockchain ecosystem

TRX options launch on Blockchain.com, boosting global access to TRON's blockchain ecosystem

Blockchain.com has launched TRX options trading, providing easier access to TRON's native token through its platform. This move expands the TRON ecosystem's reach by simplifying options trading for retail and institutional users worldwide. TRON, know...

Market News
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App